RVMD – Revolution Medicines, Inc.
Revolution Medicines, Inc.RVMD
$41.09Name : Revolution Medicines, Inc.
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $7,653,752,320.00
EPSttm : -4.01
Revolution Medicines, Inc.
$41.09
2.21%$0.89Float Short %
11.66
Margin Of Safety %
Put/Call OI Ratio
0.46
EPS Next Q Diff
-0.04
EPS Last/This Y
-1.07
EPS This/Next Y
-0.33
Price
41.08
Target Price
72.36
Analyst Recom
1.08
Performance Q
4.79
Relative Volume
0.68
Beta
1.1
Ticker: RVMD
of 1
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2025-05-08 | RVMD | 41.91 | 0.99 | 0.07 | 20468 |
| 2025-05-09 | RVMD | 40.45 | 0.98 | 0.00 | 20577 |
| 2025-05-12 | RVMD | 41.9 | 0.89 | 0.08 | 21615 |
| 2025-05-13 | RVMD | 39.97 | 0.87 | 0.10 | 21864 |
| 2025-05-14 | RVMD | 39.5 | 0.87 | 0.52 | 21978 |
| 2025-05-15 | RVMD | 39.31 | 0.86 | 8.82 | 22155 |
| 2025-05-16 | RVMD | 39.47 | 0.87 | 0.00 | 22276 |
| 2025-05-19 | RVMD | 39.92 | 0.97 | 1.98 | 18818 |
| 2025-05-20 | RVMD | 40.51 | 0.97 | 1.20 | 18852 |
| 2025-05-21 | RVMD | 38.74 | 0.97 | 100.00 | 18969 |
| 2025-05-22 | RVMD | 38.79 | 0.97 | 62.67 | 18987 |
| 2025-05-23 | RVMD | 39.76 | 0.99 | 5.00 | 19135 |
| 2025-05-27 | RVMD | 36.96 | 0.99 | 1.15 | 19132 |
| 2025-05-28 | RVMD | 37.61 | 0.98 | 0.02 | 19194 |
| 2025-05-29 | RVMD | 39.08 | 0.69 | 0.24 | 23333 |
| 2025-05-30 | RVMD | 39.37 | 0.65 | 0.03 | 24796 |
| 2025-06-02 | RVMD | 40.66 | 0.54 | 0.16 | 28324 |
| 2025-06-03 | RVMD | 40.6 | 0.49 | 0.24 | 30915 |
| 2025-06-04 | RVMD | 40.4 | 0.46 | 0.11 | 31877 |
| 2025-06-05 | RVMD | 40.21 | 0.46 | 0.55 | 32007 |
| 2025-06-06 | RVMD | 41.1 | 0.46 | 0.40 | 32378 |
| Date | Symbol | Last | P/C OI | P/C Vol | Total OI |
Current Page1 of 1
of 1
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2025-05-08 | RVMD | 41.91 | -50.8 | -438.2 | -4.48 |
| 2025-05-09 | RVMD | 40.43 | -40.5 | -134.5 | -4.63 |
| 2025-05-12 | RVMD | 41.88 | -40.5 | -227.2 | -4.63 |
| 2025-05-13 | RVMD | 39.95 | -38.9 | -137.0 | -4.66 |
| 2025-05-14 | RVMD | 39.46 | -40.5 | -181.5 | -4.63 |
| 2025-05-15 | RVMD | 39.46 | -38.4 | -197.2 | -4.63 |
| 2025-05-16 | RVMD | 39.49 | -38.4 | -200.0 | -4.65 |
| 2025-05-19 | RVMD | 39.93 | -38.4 | -211.3 | -4.65 |
| 2025-05-20 | RVMD | 40.47 | -38.4 | -216.0 | -4.65 |
| 2025-05-21 | RVMD | 38.71 | -38.4 | -139.8 | -4.65 |
| 2025-05-22 | RVMD | 38.81 | -38.4 | -200.5 | -4.65 |
| 2025-05-23 | RVMD | 39.77 | -38.4 | -231.9 | -4.65 |
| 2025-05-27 | RVMD | 36.97 | -38.4 | -103.4 | -4.65 |
| 2025-05-28 | RVMD | 37.71 | -38.4 | -225.5 | -4.65 |
| 2025-05-29 | RVMD | 39.08 | -38.4 | -246.9 | -4.65 |
| 2025-05-30 | RVMD | 39.40 | -38.4 | -208.9 | -4.65 |
| 2025-06-02 | RVMD | 40.67 | -38.4 | -241.2 | -4.65 |
| 2025-06-03 | RVMD | 40.58 | -38.4 | -195.6 | -4.65 |
| 2025-06-04 | RVMD | 40.38 | -38.4 | -191.5 | -4.65 |
| 2025-06-05 | RVMD | 40.20 | -38.4 | -192.0 | -4.65 |
| 2025-06-06 | RVMD | 41.08 | -38.4 | -226.8 | -4.65 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
Current Page1 of 1
of 1
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2025-05-08 | RVMD | 5.33 | 16.58 | 10.14 |
| 2025-05-09 | RVMD | 5.35 | 16.58 | 10.14 |
| 2025-05-12 | RVMD | 5.35 | 13.91 | 10.22 |
| 2025-05-13 | RVMD | 5.35 | 13.91 | 10.22 |
| 2025-05-14 | RVMD | 5.35 | 13.91 | 10.22 |
| 2025-05-15 | RVMD | 5.35 | 13.91 | 10.22 |
| 2025-05-16 | RVMD | 5.43 | 13.91 | 10.22 |
| 2025-05-19 | RVMD | 5.43 | 12.32 | 10.22 |
| 2025-05-20 | RVMD | 5.43 | 12.32 | 10.22 |
| 2025-05-21 | RVMD | 5.43 | 12.32 | 10.22 |
| 2025-05-22 | RVMD | 5.43 | 12.32 | 10.22 |
| 2025-05-23 | RVMD | 5.43 | 12.32 | 10.22 |
| 2025-05-27 | RVMD | 5.43 | -0.88 | 10.22 |
| 2025-05-28 | RVMD | 5.43 | -0.88 | 11.66 |
| 2025-05-29 | RVMD | 5.43 | -0.88 | 11.66 |
| 2025-05-30 | RVMD | 5.43 | -0.88 | 11.66 |
| 2025-06-02 | RVMD | 5.43 | -0.57 | 11.66 |
| 2025-06-03 | RVMD | 5.43 | -0.57 | 11.66 |
| 2025-06-04 | RVMD | 5.43 | -0.57 | 11.66 |
| 2025-06-05 | RVMD | 5.43 | -0.57 | 11.66 |
| 2025-06-06 | RVMD | 5.43 | -0.57 | 11.66 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
Current Page1 of 1
Last Quarter Act. EPS
-1.13
Avg. EPS Est. Current Quarter
-1.12
Avg. EPS Est. Next Quarter
-1.17
Insider Transactions
5.43
Institutional Transactions
-0.57
Beta
1.1
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
9
Growth Score
25
Sentiment Score
89
Actual DrawDown %
34.2
Max Drawdown 5-Year %
-73.3
Target Price
72.36
P/E
Forward P/E
PEG
P/S
P/B
3.68
P/Free Cash Flow
EPS
-4
Average EPS Est. Cur. Y
-4.65
EPS Next Y. (Est.)
-4.98
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.68
Return on Equity vs Sector %
-57.6
Return on Equity vs Industry %
-39.6
EPS 1 7Days Diff
EPS 1 30Days Diff
-0.17
EBIT Estimation
-226.8
Revolution Medicines, Inc.Sector: Healthcare
Industry: Biotechnology
Employees: 616
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers. The company's research and development pipeline consist of RAS(ON) inhibitors that binds RAS variants to be used as monotherapy in combination with other RAS(ON) inhibitors and/or in combination with RAS companion inhibitors or other therapeutic agents, and RAS companion inhibitors to suppress cooperating targets and pathways that sustain RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291), and zoldonrasib G12D (RMC-9805), which are in phase 1 clinical trial; and development candidates comprise RMC-5127 (G12V), RMC-0708 (Q61H), and RMC-8839 (G13C). The company's RAS companion inhibitors include RMC-4630 that is in phase 2 clinical trial; RMC-5552, a selective inhibitor of mTORC1 signaling in tumors, which is in phase 1 clinical trial; and RMC-5845 that targets SOS1. Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
stock quote shares RVMD – Revolution Medicines, Inc. Stock Price stock today
news today RVMD – Revolution Medicines, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch RVMD – Revolution Medicines, Inc. yahoo finance google finance
stock history RVMD – Revolution Medicines, Inc. invest stock market
stock prices RVMD premarket after hours
ticker RVMD fair value insiders trading